Tackling TKI resistance in AML: A commentary on "Inhibition of BCL2A1 by STAT5 inactivation overcomes resistance to targeted therapies of FLT3-ITD/D835 mutant AML." by Yamatani et al.

Hatırnaz Ng Ö., Eşkazan A. E.

Translational oncology, vol.19, pp.101394, 2022 (SCI-Expanded, Scopus) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 19
  • Publication Date: 2022
  • Doi Number: 10.1016/j.tranon.2022.101394
  • Journal Name: Translational oncology
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, EMBASE, Directory of Open Access Journals
  • Page Numbers: pp.101394
  • Keywords: Acute myeloid leukemia, AML, FLT3, FLT3-ITD/D835, BCL2A1, Resistance
  • Istanbul University-Cerrahpasa Affiliated: Yes